← Leaderboards
Paul Chaplin
Bavarian Nordic A/S
$8,565,623
Attributed
$8,565,623
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.4M · FY2006–14$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$8,565,623 · 3
By mechanism
N01$8,565,623 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Stability Testing”
- David Heimbrook · Leidos Biomedical Research, Inc.$83,239,517
- Thomas Macvittie · University Of Maryland Baltimore$64,108,499
- Polly Chang · Sri International$60,528,575
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Richard A Miech · Johns Hopkins University$45,487,909
- John Taber · Earthscope Consortium Inc.$38,720,068
Research focus
Stability TestingContractsVaccinesValidationAdvanced DevelopmentDrug FormulationsAwardClinical ResearchCyclic GmpDesignFilovirusImmune ResponseInvestigational DrugsProduct DevelopmentReagentTechnology DevelopmentToxicologyViral Hemorrhagic FeversAtopic DermatitisLicensureMaintenanceManufacturing ProcessModified Vaccinia Virus AnkaraNational Institute Of Allergy And Infectious Disease
Grant awards (4)
DEVELOPMENT OF TECHNOLOGIES THAT ACCELERATE THE IMMUNE RESPONSE TO BIODEFENSE VACCINES$3,593,334
N01 · FY2014 · AI · contact PI
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine$544,748
N01 · FY2013 · AI · contact PI
Development of Technologies that Accelerate the Immune Response to Vaccines$4,427,541
N01 · FY2012 · AI · contact PI
PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA /MVA/ VACCINE.-266000072$0
N01 · FY2006 · AI · contact PI